Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol
Peter Tugwell(University of Ottawa), Peter K. K. Wong(Frederiksberg Hospital), Robin Christensen(University of Copenhagen), Karine Toupin‐April(Children's Hospital of Eastern Ontario), Dorcas Beaton(University of Toronto), Mary A. De Vera, Geraldine Hassett(University of Ottawa), Bart J. F. van den Bemt(The University of Sydney), Ayano Kelly, Allison Tong(The University of Sydney), Jonathan C. Craig(Flinders University), Alexa Meara(The Ohio State University Wexner Medical Center), Lyn March(The University of Sydney), Maarten de Wit(Cal Humanities), Armando Teixeira‐Pinto(The University of Sydney), Robby Nieuwlaat(World Health Organization - Pakistan), Jasvinder A. Singh(University of Alabama at Birmingham), Vicki Evans(Brien Holden Vision Institute), Michael Gill, Susan J. Bartlett(McGill University Health Centre), María E. Suarez‐Almazor(The University of Texas MD Anderson Cancer Center), Rieke Alten(Schlosspark-Klinik), Yomei Shaw(University of Alabama at Birmingham), Renske C. F. Hebing(The Ohio State University Wexner Medical Center), Daniel Sumpton, Willemina Campbell(Toronto Western Hospital), Kathleen Tymms(Canberra Hospital), Therese Dawson(Mayo Hospital)
Cited by 57
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k